What You Should Know:
– Mayo Clinic Platformv and Techcyte have joined forces to revolutionize the field of pathology by creating a digital pathology platform. This platform aims to pioneer the next generation of pathology services through an open, AI-driven solution, enhancing treatment, efficiency, and accuracy globally.
– By enabling healthcare organizations to economically digitize their pathology practices, the platform integrates innovative technical and AI workflow solutions.
Transform Global Practice of Pathology
The collaborative effort emphasizes patient-centric innovation and brings together diverse stakeholders, including pathologists, LIS vendors, whole slide scanner manufacturers, AI providers, and more. The platform, an extension of Techcyte’s clinical pathology platform, unifies clinical and anatomic pathology into a comprehensive solution, marking a significant advancement in diagnostic practices.
“Mayo Clinic puts the needs of the patient first. That inspires us to innovate, discovering new cures and testing new care models across the many domains of medicine. Our collaboration with Techcyte will produce a global digital pathology platform, bringing together privacy-protected data sources, solution developers, and caregivers,” says John Halamka, M.D., president of Mayo Clinic Platform.
